/SILK
SILK Stock - Silk Road Medical, Inc
Healthcare|Medical - DevicesNASDAQ
$27.49-0.04%
$0.01 (-0.04%) • Sep 16
70
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.83
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).78
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.58
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+13.9%upside
Target: $31.31
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for SILK
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$27.22 – $27.76
TARGET (TP)$31.31
STOP LOSS$25.29
RISK/REWARD1:1.7
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.54
52W High$27.51
52W Low$6.08
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | $177.13M | $138.64M | $101.47M | $75.23M | $63.35M |
| Gross Profit | $127.09M | $100.76M | $76.03M | $53.94M | $47.43M |
| Gross Margin | 71.7% | 72.7% | 74.9% | 71.7% | 74.9% |
| Operating Income | $-59,271,000 | $-52,004,000 | $-47,468,000 | $-42,859,000 | $-28,065,000 |
| Net Income | $-55,743,000 | $-58,016,000 | $-50,387,000 | $-50,385,000 | $-56,073,000 |
| Net Margin | -31.5% | -41.8% | -49.7% | -67.0% | -88.5% |
| EPS | $-1.44 | $-1.62 | $-1.45 | $-1.53 | $-2.44 |
Company Overview
Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
9
45%
Hold / Neutral
6
30%
Sell / Underperform
5
25%
Analyst Consensus🔴 Bearish
9 Bullish11 Neutral/Bearish
Price Targets
$33
Average Target
↑ 19.2% Upside
Now
$8
Low
$33
Average
$60
High
Based on 17 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| July 11th 2024 | Argus | Downgrade | Sell | - |
| March 7th 2024 | Argus | Upgrade | Buy | $24 |
| January 19th 2024 | Stifel | Upgrade | Buy | $20← $9 |
| January 3rd 2024 | Lake Street | Initiation | Buy | $20 |
| October 24th 2023 | Wolfe Research | Upgrade | Peer Perform | - |
| October 11th 2023 | B. Riley Securities | Downgrade | Neutral | $14← $54 |
| October 11th 2023 | CL King | Downgrade | Neutral | - |
| October 11th 2023 | Stifel | Downgrade | Hold | $12← $45 |
| October 11th 2023 | Citigroup | Downgrade | Sell | $8← $35 |
| September 21st 2023 | Argus | Downgrade | Hold | - |
| September 6th 2023 | Oppenheimer | Initiation | Outperform | $30 |
| July 12th 2023 | BofA Securities | Downgrade | Underperform | $28← $51 |
| July 12th 2023 | JP Morgan | Downgrade | Neutral | $28← $50 |
| May 23rd 2023 | CL King | Initiation | Buy | $47 |
| May 15th 2023 | Wolfe Research | Downgrade | Underperform | $27 |
Earnings History & Surprises
SILKBeat Rate
55%
Last 20 quarters
Avg Surprise
+0.2%
EPS vs Estimate
Beats / Misses
11/8
1 met exactly
Latest EPS
$-0.42
Q3 2024
EPS Surprise History
Q4 22
+34.1%
$-0.29vs$-0.44
Q1 23
+8.1%
$-0.34vs$-0.37
Q2 23
-10.3%
$-0.43vs$-0.39
Q3 23
+10.3%
$-0.35vs$-0.39
Q4 23
+8.3%
$-0.33vs$-0.36
Q1 24
+17.5%
$-0.33vs$-0.40
Q2 24
+10.0%
$-0.36vs$-0.40
Q3 24
-10.5%
$-0.42vs$-0.38
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2024 | Aug 7, 2024 | $-0.38 | $-0.42 | -10.5% | ✗ MISS |
Q2 2024 | Apr 30, 2024 | $-0.40 | $-0.36 | +10.0% | ✓ BEAT |
Q1 2024 | Feb 28, 2024 | $-0.40 | $-0.33 | +17.5% | ✓ BEAT |
Q4 2023 | Nov 8, 2023 | $-0.36 | $-0.33 | +8.3% | ✓ BEAT |
Q3 2023 | Aug 1, 2023 | $-0.39 | $-0.35 | +10.3% | ✓ BEAT |
Q2 2023 | May 9, 2023 | $-0.39 | $-0.43 | -10.3% | ✗ MISS |
Q1 2023 | Feb 28, 2023 | $-0.37 | $-0.34 | +8.1% | ✓ BEAT |
Q4 2022 | Nov 8, 2022 | $-0.44 | $-0.29 | +34.1% | ✓ BEAT |
Q3 2022 | Jul 26, 2022 | $-0.47 | $-0.44 | +6.4% | ✓ BEAT |
Q2 2022 | May 4, 2022 | $-0.41 | $-0.48 | -17.1% | ✗ MISS |
Q1 2022 | Feb 24, 2022 | $-0.40 | $-0.42 | -5.0% | ✗ MISS |
Q4 2021 | Nov 9, 2021 | $-0.31 | $-0.40 | -29.0% | ✗ MISS |
Q3 2021 | Jul 29, 2021 | $-0.37 | $-0.31 | +16.2% | ✓ BEAT |
Q2 2021 | May 4, 2021 | $-0.40 | $-0.31 | +22.5% | ✓ BEAT |
Q1 2021 | Mar 1, 2021 | $-0.30 | $-0.49 | -63.3% | ✗ MISS |
Q4 2020 | Nov 10, 2020 | $-0.28 | $-0.31 | -10.7% | ✗ MISS |
Q3 2020 | Aug 5, 2020 | $-0.38 | $-0.32 | +15.8% | ✓ BEAT |
Q2 2020 | Apr 30, 2020 | $-0.31 | $-0.32 | -3.2% | ✗ MISS |
Q1 2020 | Feb 26, 2020 | $-0.27 | $-0.27 | 0.0% | = MET |
Q4 2019 | Oct 29, 2019 | $-0.27 | $-0.26 | +3.7% | ✓ BEAT |
Latest News
Loading news...
Frequently Asked Questions about SILK
What is SILK's current stock price?
Silk Road Medical, Inc (SILK) is currently trading at $27.49 per share. The stock has moved -0.04% today.
What is the analyst price target for SILK?
The average analyst price target for SILK is $31.31, based on 1 analyst.
What sector is Silk Road Medical, Inc in?
Silk Road Medical, Inc operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the NASDAQ exchange.
What is SILK's market cap?
Silk Road Medical, Inc has a market capitalization of $1.12 billion, making it a small-cap company.
Does SILK pay dividends?
No, Silk Road Medical, Inc does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorCINC
CinCor Pharma, Inc.
$29.06
Mkt Cap: $1.3B
CSII
Cardiovascular Systems, Inc.
$20.00
Mkt Cap: $0.8B
CTIC
CTI BioPharma Corp.
$9.10
Mkt Cap: $1.2B
EQRX
EQRx, Inc.
$2.34
Mkt Cap: $1.1B
ETHZ
Ethzilla Corp.
$6.90
Mkt Cap: $0.1B
FNA
Paragon 28, Inc.
$13.09
Mkt Cap: $1.1B
GRCL
Gracell Biotechnologies Inc.
$10.25
Mkt Cap: $0.2B
HSKA
Heska Corporation
$119.99
Mkt Cap: $1.3B
VECT
VectivBio Holding AG
$16.87
Mkt Cap: $1.1B
Explore stocks similar to SILK for comparison